Science Current Events | Science News | Brightsurf.com
 
Email a Friend Send to a friend
Printer Friendly Print Epsilon4 allele carriers show altered brain activity before onset of Alzheimer's symptoms

Epsilon4 allele carriers show altered brain activity before onset of Alzheimer's symptoms

January 13, 2006

Healthy individuals who are at risk of Alzheimer's disease show reduced activity in the hippocampal region of the brain when performing tasks related to forming new memories. In a study published today in the open access journal BMC Medicine, individuals carrying the apolipoprotein E (APOE) epsilon4 allele, which has previously been associated with high risk of developing Alzheimer's disease (AD), showed altered brain activity compared to APOE epsilon3 homozygotes. According to the authors of the study, this supports the idea that certain regions of the brain exhibit functional decline associated with the AOPE epsilon4 allele, and this decline begins before the onset of AD symptoms.

Mehul Trivedi and colleagues from the University of Wisconsin Medical School and the William S. Middleton Memorial VA Hospital, Madison, United States, used functional magnetic resonance imaging (fMRI) scanning to analyse the brain activity patterns of 40 apparently healthy middle-aged individuals with a family history of AD, comparing epsilon3/4 heterozygotes with epsilon3/3 homozygotes. In this test the participants were asked to distinguish between images that they were being shown for the first time and images that they had already memorized previously in a pre-scan training session.




During the task, the epsilon3/4 heterozygotes showed reduced activation in the medial temporal lobe (MTL) of the brain, including the right hippocampus, compared to the epsilon3/3 homozygotes. There were no differences between the two groups in age, education, performance during the task or neuropsychological assessment of memory; therefore the altered brain activation seen could not have been caused by impaired cognitive function. According to the authors, "if compromised MTL function continues to be observed in healthy epsilon4 carriers, this group of subjects may represent a good study population for novel treatments designed to delay the onset or to prevent the development of AD".

BioMed Central



Related Alzheimers Disease Current Events and Alzheimers Disease News Articles Alzheimers Disease Current Events and Alzheimers Disease News RSS Alzheimers Disease Current Events and Alzheimers Disease News RSS
Cold sore virus might play role in Alzheimer's disease
A gene known to be a major risk factor for Alzheimer's disease puts out the welcome mat for the virus that causes cold sores, allowing the virus to be more active in the brain compared to other forms of the gene.

Study offers window into human behavior, brain disease
UCSF scientists have identified a cell population that is a primary target of the degenerative brain disease known as frontotemporal dementia, which is as common as Alzheimer's disease in patients who develop dementia before age 65.

New imaging compound might 'see' Alzheimer's earlier
A new imaging molecule that can detect and map plaques and tangles in the brains of people with Alzheimer's disease could eventually lead to earlier diagnosis of the devastating disease, researchers at the University of California, Los Angeles report in the Dec. 21, 2006, issue of the New England Journal of Medicine.

Testosterone therapy may prevent Alzheimer's disease
Researchers at the University of Southern California have discovered a direct link between loss of testosterone and the development of an Alzheimer's-like disease in mice. They also discovered that testosterone treatment slows progression of the disease.

Androgen therapy may slow progress of Alzheimer's disease
Experiments on mouse models of Alzheimer's disease (AD) suggest that treatment with male sex hormones might slow its progression.

Protein 'fingerprint' in spinal fluid could spot Alzheimer's disease
Scientists collaborating at Cornell University in Ithaca and Weill Cornell Medical College in New York City have identified a panel of 23 protein biomarkers in cerebrospinal fluid that acts as a neurochemical "fingerprint," which doctors might use someday to identify patients living with Alzheimer's disease.

Study shows cats can succumb to feline Alzheimer's disease
Ageing cats can develop a feline form of Alzheimer's disease, a new study reveals. Scientists at the Universities of Edinburgh, St Andrews, Bristol and California have identified a key protein which can build up in the nerve cells of a cat's brain and cause mental deterioration.

Scientists develop a new way to target Alzheimer's disease
The pathological embrace between two proteins plays a key role in the development of Alzheimer's disease by triggering the formation of neuron-killing plaques of amyloid beta protein. Now a group of scientists at NYU School of Medicine have devised a way to reduce amyloid beta deposition by interfering with the deadly embrace of these proteins.

Complaints About Memory Are Associated With Alzheimer-Related Brain Damage
Researchers at Rush University Medical Center found that having complaints about memory problems is associated with changes in the brain related to Alzheimer's disease. They reported their findings in the November 2006 issue of Neurology.

More insight into Alzheimer's disease with Stanford discovery of possible cause
A peacekeeper in the body's defenses against infection may hold the key to understanding-and eventually treating-Alzheimer's disease. Researchers at the Stanford University School of Medicine discovered that when a molecule responsible for dialing down the immune system malfunctions in the brain cells of mice, the rodents develop symptoms of the degenerative brain disease.
More Alzheimers Disease Current Events and Alzheimers Disease News Articles


A Caregiver's Guide to Alzheimer's Disease: 300 Tips for Making Life Easier

An estimated 5 million Americans have Alzheimer's disease. That number continues to grow — by 2050 the number of individuals with Alzheimer's could range from 11.3 million to 16 million. Alzheimer's disease is not a normal part of aging. It is a devastating disorder of the brain's nerve cells that impairs memory, thinking, and behavior. Winner of the 2006 American Journal of Nursing Book of...



My Journey into Alzheimer's Disease
by Robert Davis

A book of encouragement of how one man of faith faced the oncoming darkness of Alzheimer's disease. In a powerful story of courage and faith, Davis shows how God gives strength and...



Alzheimer's Disease & Related Dementias: A Guidebook for Care, Comfort, Legal and Financial Security
by The Center for Elder Law, Home Instead Senior Care

A guidebook for those serving as caregivers to those with Alzheimer's disease and other related dementias. Section Titles Include: What is Alzheimer's and Dementia?; Medicaid Basics; What is a Will, and How Does a Will Work; Revocable Living Trust: What You Need to Know; Durable Power of Attorney & Elder Law Power of Attorney; Improved Pension Benefits for Veterans and Their Spouses; What...



Beating Alzheimer's: A Step Towards Unlocking the Mysteries of Brain Diseases
by Tom Warren



Alzheimer's Disease
by Paul Dash, Nicole Villemarette-Pittman, M.D., Paul Dash, Ph.D., Nicole Villemarette-Pittman

Alzheimer's Disease provides an overview of the latest findings regarding the cause, diagnosis, and treatment of Alzheimer's disease. It will help caregivers and family members gain a better understanding of the nature of the disease process and the available options for coping with and managing this illness. Chapters include an introduction to dementia and Alzheimer's disease; aging; memory;...

Alzheimer's Disease: Activities That Work
by Catherine Abrignani



Learning to Speak Alzheimer's: A Groundbreaking Approach for Everyone Dealing with the Disease
by Joanne Koenig Coste

More than four million Americans suffer from Alzheimer's, and as many as twenty million have close relatives or friends with the disease. Revolutionizing the way we perceive and live with Alzheimer's, Joanne Koenig Coste offers a practical approach to the emotional well-being of both patients and caregivers that emphasizes relating to patients in their own reality. Her accessible and...



American Psychiatric Publishing Textbook of Alzheimer's Disease and Other Dementias

The American Psychiatric Publishing Textbook of Alzheimer Disease and Other Dementias is an up-to-date and comprehensive overview of dementia for psychiatrists and other health care practitioners who deal with cognitively impaired adults in outpatient, inpatient, and long-term care settings. With content ranging from clinical guidance to basic research, it contains information on nearly every...



The 36-Hour Day: A Family Guide to Caring for Persons with Alzheimer Disease, Related Dementing Illnesses, and Memory Loss in Later Life (3rd Edition)
by Nancy L. Mace, Peter V. Rabins

When someone in your family suffers from Alzheimer's disease or other related memory loss diseases, both you and your loved one face immense challenges. For over 20 years this book has been the trusted bible for families affected by dementia disorders. This authoritative guie provides all the practical and specific advice you need to make care easier, improve quality of life and lift the whole...



Alzheimer's from the Inside Out
by Richard Taylor

Richard Taylor has lived for five years with a diagnosis of dementia probably of the Alzheimer's type. A former psychologist, he is now a champion for individuals with early-stage and early-onset Alzheimer's disease. Richard served on the board of the Houston and Southeast Texas Alzheimer's Association and is now a member of a special committee of the National Alzheimer's Association looking at...

© 2008 BrightSurf.com